
Benjamin Kelemen
@ben_kelemen
Interventional and critical care cardiologist. Midwest transplant to SF via Baltimore. Enjoys runs in Marin. Tweets are my own.
ID: 1242938425365295104
25-03-2020 22:16:38
1,1K Tweet
623 Takipçi
501 Takip Edilen

Incredibly grateful for the support. Many thanks to my mentors (past and current Isha Jain Javid Moslehi KaelinLab, many others) and UCSF Cardiology UC San Francisco

Matthew Sample 100% of anything probably isn’t appropriate. If you can’t offer patients radial because you don’t have that skill set - it’s time and your lab needs to address that. If you’re 100% radial and you don’t have the ability to safely access a femoral - it’s time and your lab needs to

.Interventional Cardiology at Fort Miley was the 1st VA site in the #US to treat a patient using Boston Scientific’s AGENT Paclitaxel drug-coated balloon (DCB) to treat in-stent restenosis. Dr. Jeffrey Zimmet worked with fellows Rahul Goli & Nicky Herrick during the procedure. Joseph Yang Evelyn J. Song


👋An official welcome to Dr. Amir Munir who starts today. We are excited to have you at UCSF Health! #UCSFCardiology



Congrats 2 Mandar Aras, MD, PhD for his promotion to Associate Professor UCSF Cardiology! Mandar leads our amyloid program in the Section of #CardioOnc & Immunology! Lots of developments in amyloidosis. Looking forward to #ESC2024 for new treatments being announced!



Alex Truesdell Any thoughts on rescuing that LIMA?

Sachin Goel MIЯVΛƬ #IC ༄ 。° European Society of Cardiology PCRonline 🫀 NEJM Salvatore Brugaletta Khaled AlShaibi Didier Tchetche Victoria Delgado Javier Escaned Ritu Thamman MD Aditya Bharadwaj Tom Johnson Nieves Gonzalo Greater than or equal to, which is probably an important hair to split. I was pleased to see that their findings agree with "Cohen's rule" as well-- never treat a lesion that is less severe than the patient's age (median age in NOTION 3 was 82).

Navin Kapur Sunil V. Rao Jason N. Katz And if one accepts that logic, then it’s equally critical for the tertiary/quartenary center to have an “open door” transfer policy— much like many do for STEMI. Otherwise, we are doomed to fail.


John Mandrola, MD I am not an oncologist but when the median overall survival is 17 months with standard of care, additional 3 months is clinically significant. If QOL is maintained, this can mean a lot more meaningful life moments for patients.

Proud to announce the creation of the UCSF Pericarditis Center led by Alan Baik! Great addition to UCSF Cardiology Section of #CardioOnc & Immunology! Website made by UCSF Department of Medicine PGY2 resident extraordinaire Aishwarya Nene, MD MPhil! Bob Wachter Mandar Aras, MD, PhD ucsfhealthcardiology.ucsf.edu/patient-care/c…




Great spotlight on Amir Munir! Dr. Munir completed #CardioOnc fellowship at UCSF Cardiology & just joined our faculty. He has been identifying novel mediators of myocarditis including chemokine receptors! Sarnoff Foundation UCSF Helen Diller Family Comprehensive Cancer Ctr ucsfhealthcardiology.ucsf.edu/facstaff/spotl…

Anthony DiGiorgio, DO, MHA If you start from a place of “in what world does a government run bureaucracy operate more efficient than a private market” you end at “Medicaid only appears more efficient” and “that’s just their admin budget” 😒 Circular ⭕️ logic again…

📢 Our new study is out in JACC Journals 🔍 In patients aged 65 and older undergoing SAVR, nearly 50% undergo concomitant procedures, which are associated with increased short- and long-term mortality. 👉 jacc.org/doi/10.1016/j.… #TAVR Cardiovascular Research Foundation David J. Cohen, MD, MSc Jeffrey Popma
